Edwards Lifesciences (EW) Non-Current Receivables (2011 - 2016)

Edwards Lifesciences' Non-Current Receivables history runs 6 years deep, the most recent figure standing at $5.3 million for Q3 2016.

• In Q3 2016, Non-Current Receivables fell 3.64% year-over-year to $5.3 million; the TTM figure through Sep 2016 stood at $5.3 million (down 3.64% YoY), while the FY2015 annual figure was $3.6 million, down 37.93% from the prior year.
• Non-Current Receivables was $5.3 million for Q3 2016 at Edwards Lifesciences, roughly flat from $5.3 million in the prior quarter.
• In the past five years, Non-Current Receivables ranged from a high of $21.4 million in Q1 2012 to a low of $3.6 million in Q4 2015.
• Historically, Non-Current Receivables has averaged $8.4 million across 5 years, with a median of $7.3 million in 2013.
• The sharpest annual moves came in 2012 and 2013: Non-Current Receivables sank 59.76% in 2012, then increased 19.27% in 2013.
• A 5-year view of Non-Current Receivables shows it stood at $9.9 million in 2012, then dropped by 26.26% to $7.3 million in 2013, then retreated by 20.55% to $5.8 million in 2014, then plunged by 37.93% to $3.6 million in 2015, then soared by 47.22% to $5.3 million in 2016.
• The last three Non-Current Receivables figures came in at $5.3 million (Q3 2016), $5.3 million (Q2 2016), and $5.8 million (Q1 2016), per Business Quant data.